nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)

Morgensztern, D; Dols, MC; Aix, SP; Postmus, PE; Bennouna, J; Fischer, JR; Juan-Vidal, O; Stewart, DJ; Ardizzoni, A; Bhore, R; Wolfsteiner, M; Reck, M; Talbot, D; Govindan, R; Ong, TJ – 2021